Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  



























Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Timeline  



1.1  May 2020  





1.2  June 2020  





1.3  July 2020  





1.4  August 2020  





1.5  September 2020  





1.6  October 2020  





1.7  November 2020  





1.8  December 2020  





1.9  January 2021  





1.10  February 2021  





1.11  March 2021  





1.12  April 2021  





1.13  May 2021  





1.14  June 2021  





1.15  July 2021  





1.16  August 2021  





1.17  September 2021  





1.18  Oct to Dec 2021  





1.19  Jan to Mar 2022  





1.20  April to June 2022  





1.21  July to September 2022  







2 Sample Testing  





3 COVID-19 Vaccines with Approval for Emergency or Conditional Usage  



3.1  Covishield  





3.2  Covaxin  





3.3  Others  







4 See also  





5 Notes  





6 References  





7 External links  














COVID-19 pandemic in Tripura






العربية
Bahasa Indonesia
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 


















From Wikipedia, the free encyclopedia
 


COVID-19 pandemic in Tripura
DiseaseCOVID-19
Virus straincorona-CoV-2
LocationTripura, India
First outbreakWuhan, Hubei, China
Index caseChandigarh
Arrival date6 April 2020
(4 years, 1 month and 4 weeks)[1]
Confirmed cases1,240 (22 June 2020)
Active cases453[note 1]
Recovered782 (22 June 2020)

Deaths

1 (9 June 2020)
Fatality rate0.08%
Government website
COVID-19 dashboard

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Tripura. The first case was recorded in this region on 6 April.[1]

Timeline[edit]

May 2020[edit]

June 2020[edit]

July 2020[edit]

August 2020[edit]

September 2020[edit]

October 2020[edit]

November 2020[edit]

December 2020[edit]

January 2021[edit]

February 2021[edit]

March 2021[edit]

April 2021[edit]

May 2021[edit]

June 2021[edit]

July 2021[edit]

August 2021[edit]

September 2021[edit]

Oct to Dec 2021[edit]

Jan to Mar 2022[edit]

April to June 2022[edit]

July to September 2022[edit]

Sample Testing[edit]

Summary of test results
Samples tested 56,035
Tested Positive 1,240
Tests per million[note 2] 14,037
Percentage Tested Positive 2.21%
As of 22 June 2020

COVID-19 Vaccines with Approval for Emergency or Conditional Usage[edit]

Union Minister for Health & Family Welfare, Dr. Harsh Vardhan visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on January 02, 2021.

Covishield[edit]

On January 1, 2021, the Drug Controller General of India, approved the emergency or conditional use of AstraZeneca's COVID-19 vaccine AZD1222 (marketed as Covishield).[6] Covishield is developed by the University of Oxford and its spin-out company, Vaccitech.[7] It's a viral vector vaccine based on replication-deficient Adenovirus that causes cold in Chimpanzees. It can be stored, transported and handled at normal refrigerated conditions (two-eight degrees Celsius/ 36-46 degrees Fahrenheit). It has a shelf-life of at least six months.

On 12 January 2021 first batches of Covishield vaccine was despatched from the Serum Institute of India.[8]

Covaxin[edit]

On January 2, 2021, BBV152 (marketed as Covaxin), first indigenous vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology received approval from the Drug Controller General of India for its emergency or conditional usage.[9]

On 14 January 2021 first batches of Covaxin vaccine was despatched from the Bharat Biotech, albeit it was still in the third phase of testing.[10]

Others[edit]

On 19 May 2021, Dr Reddy's Labs received Emergency Use Authorisation for anti-COVID drug 2-DG.[11] On 21 February, 2022, Drugs Controller General of India granted approval to Biological E's COVID-19 vaccine Corbevax, that can be used for children between 12 and 18 years of age.[12][13]

On 21 October 2021, India completed administering of one billion Covid vaccines in the country.[14]

On 8 January 2022, India crossed 1.5 billion Covid vaccines milestone in the country.[15]

On 19 February 2022, India crossed 1.75 billion Covid vaccines milestone in the country.[16]

See also[edit]

Notes[edit]

  1. ^ 4 persons migrated, are not included here
  • ^ Population based on 2019 estimates from National Health Mission[5]
  • References[edit]

    1. ^ a b Loiwal, Manogya (6 April 2020). "Coronavirus in India: Woman tests positive for Covid-19 in Agartala, first case in Tripura". India Today. Retrieved 14 May 2020.
  • ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au av aw ax ay az ba bb bc bd be bf bg bh bi bj bk bl bm bn bo bp bq br bs bt bu bv bw "MoHFW-GOI". Ministry of Health and Family Welfare. Retrieved 23 May 2020.
  • ^ Ali, Syed Sajjad (27 August 2020). "Tripura surpasses 10,000 coronavirus cases". The Hindu. Retrieved 2 September 2020.
  • ^ a b c d e f g h i j k l m n o p q r s t u v "COVID19 STATEWISE STATUS". MyGov.in. 28 March 2020. Retrieved 14 December 2021.
  • ^ "Report_Population_Projection_2019.pdf" (PDF). NHM India. Retrieved 19 June 2020.
  • ^ "COVID-19 vaccine Covishield gets approval from DCGI's expert panel". The Hindu. 1 January 2021. Retrieved 4 January 2021.
  • ^ "AstraZeneca's COVID-19 vaccine authorised for emergency supply in the UK". AstraZeneca. AstraZeneca. 30 December 2020. Retrieved 4 January 2021.
  • ^ "Stand By, India: Serum Institute Sends Out Vaccines, 1st Batch In Delhi". NDTV. 12 January 2021. Retrieved 12 January 2021.
  • ^ "Expert panel recommends Bharat Biotech's Covaxin for restricted emergency use". News18. 2 January 2021. Retrieved 4 January 2021.
  • ^ "Covaxin delivery starts, 'full initial procurement allotted'". Indian Express. 14 January 2021. Retrieved 14 January 2021.
  • ^ "Dr Reddy's confirms Emergency Use Authorisation for anti-COVID drug 2-DG, says price not yet fixed". Moneycontol. 19 May 2021. Retrieved 20 May 2021.
  • ^ "Approval granted to COVID vaccine Corbevax for children between 12-18 years". Times of India. 21 February 2022. Retrieved 22 February 2022.
  • ^ "Biological E's Covid vaccine Corbevax receives emergency use nod for children aged 12-18 yrs". Hindustan Times. 21 February 2022. Retrieved 22 February 2022.
  • ^ "India scripts history, administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021.
  • ^ "India crosses 1.5 bn Covid vaccine doses, Modi terms it 'significant milestone'". Hindustan Times. 9 January 2022. Retrieved 16 January 2022.
  • ^ "COVID-19: India's vaccination coverage crosses 175 crore mark". DNA India. 19 February 2022. Retrieved 26 February 2022.
  • External links[edit]


    Retrieved from "https://en.wikipedia.org/w/index.php?title=COVID-19_pandemic_in_Tripura&oldid=1206126352"

    Category: 
    COVID-19 pandemic in India by state or union territory
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
    Use Indian English from May 2020
    All Wikipedia articles written in Indian English
    Use dmy dates from May 2020
    Wikipedia articles in need of updating from June 2020
    All Wikipedia articles in need of updating
     



    This page was last edited on 11 February 2024, at 07:49 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki